Zai Lab Limited. (ZLAB) NASDAQ

$31.94 0.48 (1.53%)

Market Cap: $3.08B

As of 03/24/23 03:20 PM EDT. Market open.

(ZLAB)

Zai Lab Limited. (ZLAB)
NASDAQ

$31.94
0.48 (1.53%)

Market Cap: $3.08B

As of 03/24/23 03:20 PM EDT. Market open.

Zai Lab ) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China's pharmaceutical market and address unmet medical needs, Zai Lab's experienced team has secured partnerships with leading global ... read more

Zai Lab ) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China's pharmaceutical market and address unmet medical needs, Zai Lab's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in itsfocus areas. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
Pudong, Shanghai, Shanghai, 201210.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
1,951
Address
Pudong, Shanghai, Shanghai, 201210.
PRICE CHART FOR ZAI LAB LIMITED
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$31.04
Previous Close
$31.46
Days Range
$30.75 - $33.80
52 week range
$20.98 - $53.95
Volume
144,930
Avg. Volume (30 days)
769,930
Market Cap
$3.08B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
97,908,700
Open
$31.04
Previous Close
$31.46
Days Range
$30.75 - $33.80
52 week range
$20.98 - $53.95
Volume
144,930
Avg. Volume (30 days)
769,930
Market Cap
$3.08B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
97,908,700

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ZAI LAB LIMITED
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Du YingChairperson & CEOMar 06, 2023 Option Exercise$40.55120,9064,902,738994,089Mar 08, 2023, 04:11 PM
Du YingChairperson & CEOMar 06, 2023 Option Exercise$0.60300,000180,0001,114,995Mar 08, 2023, 04:11 PM
Edmondson Frazor Titus IIIChief Legal OfficerMar 06, 2023 Sale$40.557,965322,98119,400Mar 07, 2023, 04:05 PM
Reinhart HaraldSee RemarksMar 03, 2023 Option Exercise$3.0011,48034,44030,438Mar 07, 2023, 04:05 PM
Reinhart HaraldSee RemarksMar 03, 2023 Sale$40.0011,480459,20018,958Mar 07, 2023, 04:05 PM
Reinhart HaraldSee RemarksDec 30, 2022 Option Exercise$30.705,903181,22218,958Jan 03, 2023, 04:05 PM
WIRTH PETERDirectorDec 08, 2021 Buy$71.364,000285,4404,000Dec 12, 2022, 04:05 PM
WIRTH PETERDirectorDec 08, 2022 Sale$35.373,852136,245342,763Dec 09, 2022, 04:05 PM
WIRTH PETERDirectorDec 08, 2022 Sale$35.334,000141,3200Dec 09, 2022, 04:05 PM
Du YingChairperson & CEOApr 01, 2022 Option Exercise$45.4782837,649978,975Dec 09, 2022, 04:05 PM
Reinhart HaraldSee RemarksApr 01, 2022 Option Exercise$45.4724611,18624,861Nov 17, 2022, 09:37 PM
Reinhart HaraldSee RemarksNov 15, 2022 Option Exercise$3.001,8545,56226,715Nov 17, 2022, 09:37 PM
Reinhart HaraldSee RemarksNov 15, 2022 Sale$40.001,85474,16324,961Nov 17, 2022, 09:37 PM
Edmondson Frazor Titus IIIChief Legal OfficerApr 01, 2022 Option Exercise$45.472039,23023,696Aug 22, 2022, 04:05 PM
Edmondson Frazor Titus IIIChief Legal OfficerAug 17, 2022 Option Exercise$43.521,18151,3977,965Aug 19, 2022, 05:44 PM
Edmondson Frazor Titus IIIChief Legal OfficerAug 17, 2022 Option Exercise$43.524,850211,0729,146Aug 19, 2022, 05:44 PM
DIEKMAN JOHN DDirectorFeb 04, 2022 Sale$50.171,00050,17067,615Feb 07, 2022, 05:22 PM
Lis WilliamDirectorJan 20, 2022 Sale$53.401,926102,84834,114Jan 21, 2022, 05:10 PM
Reinhart HaraldSee RemarksDec 29, 2021 Option Exercise$69.235,903408,66524,097Dec 30, 2021, 04:18 PM
WIRTH PETERDirectorDec 08, 2021 Buy$71.364,000285,440342,852Dec 08, 2021, 08:56 PM
Sandler Alan B.Head of Global Dev., OncologyDec 01, 2021 Option Exercise$71.232,075147,80227,925Dec 03, 2021, 06:29 PM
Edmondson Frazor Titus IIIChief Legal OfficerAug 17, 2021 Option Exercise$140.291,181165,68223,069Dec 03, 2021, 06:28 PM
DIEKMAN JOHN DDirectorNov 05, 2021 Sale$91.651,00091,65060,852Nov 08, 2021, 04:23 PM
Fu TaoPresident & COOOct 28, 2021 Sale$105.0010,0001,049,97885,435Oct 29, 2021, 05:15 PM
Fu TaoPresident & COOOct 14, 2021 Sale$102.6810,0001,026,79994,140Oct 14, 2021, 08:40 PM
Fu TaoPresident & COOSep 30, 2021 Sale$106.7310,0001,067,335104,786Oct 01, 2021, 05:37 PM
Fu TaoPresident & COOSep 24, 2021 Option Exercise$119.8619,8322,377,064187,668Sep 27, 2021, 05:58 PM
Fu TaoPresident & COOSep 15, 2021 Sale$134.0910013,409207,500Sep 27, 2021, 05:58 PM
Fu TaoPresident & COOSep 15, 2021 Option Exercise$18.9210,000189,200217,500Sep 16, 2021, 09:59 PM
Fu TaoPresident & COOSep 15, 2021 Sale$127.869,9001,265,778215,522Sep 16, 2021, 09:59 PM
Reinhart HaraldChief Medical OfficerSep 09, 2021 Option Exercise$3.0010,00030,00010,000Sep 10, 2021, 04:17 PM
Reinhart HaraldChief Medical OfficerSep 09, 2021 Sale$141.3610,0001,413,6217,269Sep 10, 2021, 04:17 PM
Reinhart HaraldChief Medical OfficerSep 07, 2021 Option Exercise$3.0010,00030,00010,000Sep 08, 2021, 09:02 PM
Reinhart HaraldChief Medical OfficerSep 07, 2021 Sale$150.9310,0001,509,2599,900Sep 08, 2021, 09:02 PM
Du YingChairwoman & CEOSep 07, 2021 Sale$150.7329,7854,489,5231,038,056Sep 08, 2021, 08:48 PM
Du YingChairwoman & CEOSep 01, 2021 Option Exercise$0.60111,11166,6671,119,764Sep 03, 2021, 06:43 PM
Du YingChairwoman & CEOSep 03, 2021 Sale$145.0424,1453,501,9401,056,500Sep 03, 2021, 06:43 PM
Du YingChairwoman & CEOSep 02, 2021 Sale$145.7928,7384,189,6101,084,070Sep 03, 2021, 06:43 PM
Du YingChairwoman & CEOSep 01, 2021 Sale$146.4628,4434,165,6971,115,598Sep 03, 2021, 06:43 PM
Fu TaoPresident & COOAug 25, 2021 Option Exercise$18.9210,000189,200217,000Aug 26, 2021, 07:12 PM
Fu TaoPresident & COOAug 25, 2021 Sale$143.0310,0001,430,285215,400Aug 26, 2021, 07:12 PM
Reinhart HaraldChief Medical OfficerAug 24, 2021 Option Exercise$17.998,000143,9208,000Aug 25, 2021, 05:47 PM
Reinhart HaraldChief Medical OfficerAug 23, 2021 Option Exercise$17.998,000143,9208,000Aug 25, 2021, 05:47 PM
Reinhart HaraldChief Medical OfficerAug 23, 2021 Sale$135.008,0001,080,0000Aug 25, 2021, 05:47 PM
Reinhart HaraldChief Medical OfficerAug 24, 2021 Sale$143.368,0001,146,8800Aug 25, 2021, 05:47 PM
DIEKMAN JOHN DDirectorAug 05, 2021 Sale$149.501,000149,50061,852Aug 05, 2021, 06:57 PM
Du YingChairwoman & CEOAug 02, 2021 Option Exercise$0.60111,11166,6671,116,649Aug 03, 2021, 08:15 PM
Du YingChairwoman & CEOAug 03, 2021 Sale$146.3826,2173,837,7591,034,489Aug 03, 2021, 08:15 PM
Du YingChairwoman & CEOAug 02, 2021 Sale$144.5684,89412,272,2561,116,649Aug 03, 2021, 08:15 PM
Fu TaoPresident & COOJul 15, 2021 Option Exercise$18.9210,000189,200217,000Jul 19, 2021, 06:02 PM
Fu TaoPresident & COOJul 15, 2021 Sale$172.8210,0001,728,189214,667Jul 19, 2021, 06:02 PM
Reinhart HaraldChief Medical OfficerJul 13, 2021 Option Exercise$18.008,000144,0008,000Jul 15, 2021, 08:05 PM
Reinhart HaraldChief Medical OfficerJul 14, 2021 Option Exercise$17.998,000143,9604,000Jul 15, 2021, 08:05 PM
Reinhart HaraldChief Medical OfficerJul 14, 2021 Sale$169.118,0001,352,8800Jul 15, 2021, 08:05 PM
Reinhart HaraldChief Medical OfficerJul 13, 2021 Sale$169.928,0001,359,3600Jul 15, 2021, 08:05 PM
Du YingChairwoman & CEOJul 01, 2021 Option Exercise$0.60111,11166,6671,119,764Jul 02, 2021, 06:02 PM
Du YingChairwoman & CEOJul 02, 2021 Sale$175.3127,2534,777,6591,021,512Jul 02, 2021, 06:02 PM
Du YingChairwoman & CEOJul 01, 2021 Sale$175.7083,85814,734,0911,078,487Jul 02, 2021, 06:02 PM
Reinhart HaraldChief Medical OfficerJun 16, 2021 Option Exercise$20.908,000167,2008,000Jun 17, 2021, 08:04 PM
Reinhart HaraldChief Medical OfficerJun 17, 2021 Option Exercise$18.008,000144,0008,000Jun 17, 2021, 08:04 PM
Reinhart HaraldChief Medical OfficerJun 17, 2021 Sale$161.648,0001,293,1200Jun 17, 2021, 08:04 PM
Reinhart HaraldChief Medical OfficerJun 16, 2021 Sale$162.718,0001,301,6800Jun 17, 2021, 08:04 PM
Fu TaoPresident & COOJun 15, 2021 Option Exercise$18.9210,000189,200217,000Jun 17, 2021, 08:01 PM
Fu TaoPresident & COOJun 15, 2021 Sale$165.2810,0001,652,786214,648Jun 17, 2021, 08:01 PM
Cho William Ki ChulChief Financial OfficerJun 02, 2021 Sale$180.691,416255,85750,000Jun 02, 2021, 09:02 PM
Cho William Ki ChulChief Financial OfficerJun 01, 2021 Sale$180.128,5841,546,15051,416Jun 02, 2021, 09:02 PM
Du YingChairwoman & CEOJun 01, 2021 Option Exercise$0.60111,11166,6671,119,764Jun 02, 2021, 09:00 PM
Du YingChairwoman & CEOJun 02, 2021 Sale$177.529,4631,679,8471,017,205Jun 02, 2021, 09:00 PM
Du YingChairwoman & CEOJun 01, 2021 Sale$176.19101,64817,909,4031,108,835Jun 02, 2021, 09:00 PM
Du YingChairwoman & CEOMay 01, 2021 Option Exercise$0.60111,11166,6671,119,764Jun 02, 2021, 08:58 PM
Reinhart HaraldChief Medical OfficerMay 25, 2021 Option Exercise$20.908,000167,2008,000May 26, 2021, 08:18 PM
Reinhart HaraldChief Medical OfficerMay 24, 2021 Option Exercise$20.908,000167,2008,000May 26, 2021, 08:18 PM
Reinhart HaraldChief Medical OfficerMay 25, 2021 Sale$161.668,0001,293,2800May 26, 2021, 08:18 PM
Reinhart HaraldChief Medical OfficerMay 24, 2021 Sale$162.378,0001,298,9600May 26, 2021, 08:18 PM
DIEKMAN JOHN DDirectorMay 05, 2021 Sale$153.621,000153,62062,852May 06, 2021, 07:49 PM
Du YingChairwoman & CEOMay 04, 2021 Sale$158.1148,9477,738,927821,998May 04, 2021, 08:37 PM
Du YingChairwoman & CEOMay 03, 2021 Sale$161.5762,16410,044,049889,331May 04, 2021, 08:37 PM
Fu TaoPresident & COOApr 19, 2021 Option Exercise$18.9210,000189,200217,000Apr 21, 2021, 08:01 PM
Fu TaoPresident & COOApr 19, 2021 Sale$162.9110,0001,629,140211,200Apr 21, 2021, 08:01 PM
Reinhart HaraldChief Medical OfficerApr 20, 2021 Option Exercise$20.908,000167,2008,000Apr 21, 2021, 07:59 PM
Reinhart HaraldChief Medical OfficerApr 21, 2021 Option Exercise$20.908,000167,2008,000Apr 21, 2021, 07:59 PM
Reinhart HaraldChief Medical OfficerApr 21, 2021 Sale$161.998,0001,295,9200Apr 21, 2021, 07:59 PM
Reinhart HaraldChief Medical OfficerApr 20, 2021 Sale$150.208,0001,201,6000Apr 21, 2021, 07:59 PM
Du YingChairwoman & CEOApr 07, 2021 Sale$134.4221,9362,948,655918,900Apr 07, 2021, 07:55 PM
Du YingChairwoman & CEOApr 06, 2021 Sale$127.2838,3924,886,566956,591Apr 07, 2021, 07:55 PM
Du YingChairwoman & CEOApr 05, 2021 Sale$126.1950,7846,408,460997,161Apr 07, 2021, 07:55 PM
Chen Kai-XianDirectorMar 12, 2021 Sale$142.534,302613,16424,662Mar 30, 2021, 08:51 PM
Fu TaoPresident & COOMar 26, 2021 Option Exercise$18.9220,000378,400207,000Mar 30, 2021, 06:48 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Du YingChairperson & CEO03/06/20234,902,738
Du YingChairperson & CEO03/06/2023180,000
Edmondson Frazor Titus IIIChief Legal Officer03/06/2023322,981
Reinhart HaraldSee Remarks03/03/202334,440
Reinhart HaraldSee Remarks03/03/2023459,200
Reinhart HaraldSee Remarks12/30/2022181,222
WIRTH PETERDirector12/08/2021285,440
WIRTH PETERDirector12/08/2022136,245
WIRTH PETERDirector12/08/2022141,320
Du YingChairperson & CEO04/01/202237,649
Reinhart HaraldSee Remarks04/01/202211,186
Reinhart HaraldSee Remarks11/15/20225,562
Reinhart HaraldSee Remarks11/15/202274,163
Edmondson Frazor Titus IIIChief Legal Officer04/01/20229,230
Edmondson Frazor Titus IIIChief Legal Officer08/17/202251,397
Edmondson Frazor Titus IIIChief Legal Officer08/17/2022211,072
DIEKMAN JOHN DDirector02/04/202250,170
Lis WilliamDirector01/20/2022102,848
Reinhart HaraldSee Remarks12/29/2021408,665
WIRTH PETERDirector12/08/2021285,440
Sandler Alan B.Head of Global Dev., Oncology12/01/2021147,802
Edmondson Frazor Titus IIIChief Legal Officer08/17/2021165,682
DIEKMAN JOHN DDirector11/05/202191,650
Fu TaoPresident & COO10/28/20211,049,978
Fu TaoPresident & COO10/14/20211,026,799
Fu TaoPresident & COO09/30/20211,067,335
Fu TaoPresident & COO09/24/20212,377,064
Fu TaoPresident & COO09/15/202113,409
Fu TaoPresident & COO09/15/2021189,200
Fu TaoPresident & COO09/15/20211,265,778
Reinhart HaraldChief Medical Officer09/09/202130,000
Reinhart HaraldChief Medical Officer09/09/20211,413,621
Reinhart HaraldChief Medical Officer09/07/202130,000
Reinhart HaraldChief Medical Officer09/07/20211,509,259
Du YingChairwoman & CEO09/07/20214,489,523
Du YingChairwoman & CEO09/01/202166,667
Du YingChairwoman & CEO09/03/20213,501,940
Du YingChairwoman & CEO09/02/20214,189,610
Du YingChairwoman & CEO09/01/20214,165,697
Fu TaoPresident & COO08/25/2021189,200
Fu TaoPresident & COO08/25/20211,430,285
Reinhart HaraldChief Medical Officer08/24/2021143,920
Reinhart HaraldChief Medical Officer08/23/2021143,920
Reinhart HaraldChief Medical Officer08/23/20211,080,000
Reinhart HaraldChief Medical Officer08/24/20211,146,880
DIEKMAN JOHN DDirector08/05/2021149,500
Du YingChairwoman & CEO08/02/202166,667
Du YingChairwoman & CEO08/03/20213,837,759
Du YingChairwoman & CEO08/02/202112,272,256
Fu TaoPresident & COO07/15/2021189,200
Fu TaoPresident & COO07/15/20211,728,189
Reinhart HaraldChief Medical Officer07/13/2021144,000
Reinhart HaraldChief Medical Officer07/14/2021143,960
Reinhart HaraldChief Medical Officer07/14/20211,352,880
Reinhart HaraldChief Medical Officer07/13/20211,359,360
Du YingChairwoman & CEO07/01/202166,667
Du YingChairwoman & CEO07/02/20214,777,659
Du YingChairwoman & CEO07/01/202114,734,091
Reinhart HaraldChief Medical Officer06/16/2021167,200
Reinhart HaraldChief Medical Officer06/17/2021144,000
Reinhart HaraldChief Medical Officer06/17/20211,293,120
Reinhart HaraldChief Medical Officer06/16/20211,301,680
Fu TaoPresident & COO06/15/2021189,200
Fu TaoPresident & COO06/15/20211,652,786
Cho William Ki ChulChief Financial Officer06/02/2021255,857
Cho William Ki ChulChief Financial Officer06/01/20211,546,150
Du YingChairwoman & CEO06/01/202166,667
Du YingChairwoman & CEO06/02/20211,679,847
Du YingChairwoman & CEO06/01/202117,909,403
Du YingChairwoman & CEO05/01/202166,667
Reinhart HaraldChief Medical Officer05/25/2021167,200
Reinhart HaraldChief Medical Officer05/24/2021167,200
Reinhart HaraldChief Medical Officer05/25/20211,293,280
Reinhart HaraldChief Medical Officer05/24/20211,298,960
DIEKMAN JOHN DDirector05/05/2021153,620
Du YingChairwoman & CEO05/04/20217,738,927
Du YingChairwoman & CEO05/03/202110,044,049
Fu TaoPresident & COO04/19/2021189,200
Fu TaoPresident & COO04/19/20211,629,140
Reinhart HaraldChief Medical Officer04/20/2021167,200
Reinhart HaraldChief Medical Officer04/21/2021167,200
Reinhart HaraldChief Medical Officer04/21/20211,295,920
Reinhart HaraldChief Medical Officer04/20/20211,201,600
Du YingChairwoman & CEO04/07/20212,948,655
Du YingChairwoman & CEO04/06/20214,886,566
Du YingChairwoman & CEO04/05/20216,408,460
Chen Kai-XianDirector03/12/2021613,164
Fu TaoPresident & COO03/26/2021378,400
Load More Insider Transactions
FUNDS WITH A POSITION IN ZAI LAB LIMITED
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.4,301,4370.00414%-0.01%Other
VIKING GLOBAL INVESTORS LP1,973,5970.3%-24.52%Growth At A Reasonable Price
BAMCO INC /NY/1,353,8150.14%-1.6%Growth At A Reasonable Price
BRIDGEWATER ASSOCIATES, LP475,0120.08%-29.16%Other
CAPITAL WORLD INVESTORS570,1440.00373%No changeGrowth At A Reasonable Price
GEODE CAPITAL MANAGEMENT, LLC456,4390.00196%0.48%Other
VIVO CAPITAL, LLC338,7211.2%24.75%Other
PLATINUM INVESTMENT MANAGEMENT LTD190,3400.22%29.24%Growth At A Reasonable Price, Value
RENAISSANCE TECHNOLOGIES LLC110,7000.00465%285.71%Other
ALPS ADVISORS INC66,4180.02%17.83%Other
D. E. SHAW & CO., INC.24,9130.00085%-0.8%Other
UBS OCONNOR LLC15,7000.01%ExitedValue
WATER ISLAND CAPITAL LLC10,0000.03%-3.38%Event Driven
CHANGE IN SHARES OUTSTANDING FOR ZAI LAB LIMITED
STOCK BUYBACKS FOR ZAI LAB LIMITED
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2022
09/30/2022
0.07%
1Q
12/31/2022
03/31/2022
0.27%
3Q

Period of Report: 12/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2022
0.07%
1Q
03/31/2022
0.27%
3Q